FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/062460 [Registered on: 08/02/2024] Trial Registered Prospectively
Last Modified On: 29/01/2024
Post Graduate Thesis  Yes 
Type of Trial  PMS 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study of oral Mifepristone as a cervical ripening agent to induce labour in low-risk full-term live pregnancy beyond 40 weeks of gestation. 
Scientific Title of Study   Study of oral Mifepristone as a cervical ripening agent to induce labour in low-risk full-term live pregnancy beyond 40 weeks of gestation - a randomized controlled trial  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nikita Yadav 
Designation  Post Graduate Student 
Affiliation  Dr. S.N. Medical College, Jodhpur 
Address  Dept of OBGYN, Labour Room, Umaid Hospital, Jodhpur, Rajasthan
Dept of OBGYN, Labour Room, Umaid Hospital, Jodhpur, Rajasthan
Jodhpur
RAJASTHAN
331305
India 
Phone  09671457133  
Fax    
Email  nikitayadav97@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Hanslata Gehlot 
Designation  Senior Professor & Unit Head 
Affiliation  Umaid Hospital, Dr. S.N. Medical College, Jodhpur 
Address  Unit-3, Dept of OBGYN, Umaid Hospital, Jodhpur, Rajasthan
Unit-3, Dept of OBGYN, Umaid Hospital, Jodhpur, Rajasthan
Jodhpur
RAJASTHAN
331305
India 
Phone  09414135070  
Fax    
Email  pummyia@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Hanslata Gehlot 
Designation  Senior Professor & Unit Head 
Affiliation  Umaid Hospital, Dr. S.N. Medical College, Jodhpur 
Address  Unit-3, Dept of OBGYN, Umaid Hospital, Jodhpur, Rajasthan
Unit-3, Dept of OBGYN, Umaid Hospital, Jodhpur, Rajasthan
Jodhpur
RAJASTHAN
331305
India 
Phone  09414135070  
Fax    
Email  pummyia@gmail.com  
 
Source of Monetary or Material Support  
Umaid Hospital- Government Medical College 
 
Primary Sponsor  
Name  Umaid Hospital, Dr SN Medical College 
Address  Umaid Hospital, Jodhpur 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikita Yadav  Umaid Hospital  Department of OBGYN, Labour room, Umaid Hospital, Dr. S.N. Medical College, Jodhpur
Jodhpur
RAJASTHAN 
9671457133

nikitayadav97@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Dr. Sampurnanand Medical College, Jodhpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Expectant Management  In the comparator arm, we will not intervene, and will do expectant management between 40-41 weeks.  
Intervention  Tab Mifepristone   We will give Tab Mifepristone 200mg orally 2 doses 24 hours apart and wait till 72 hours from the first dose for Bishop score to improve  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Pregnant females of age between 18-45 years old, Primigravida or Gravida 2, with singleton live pregnancy with cephalic presentation of gestational age 40-41 weeks without any obstetric complications, having an unripe cervix and intact membranes.
 
 
ExclusionCriteria 
Details  Pregnant females having any obstetric complications, any previous uterine surgery, any fetal compromise. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Gain in Bishops score


 
Baseline, at 24 hours, 48 hours, 72 hours from first dose of Mifepristone
 
 
Secondary Outcome  
Outcome  TimePoints 
1)Duration of induction to active phase of labour & induction to delivery interval.
2)Mode of delivery
3)Maternal & perinatal complications

 
1) When women enters active stage of labour & when she delivers
2) At delivery
3) At delivery

 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   08/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="30" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Through this study we want to see the effect of indirect labour inducing agent- Mifepristone on cervical ripening in an unripe cervix at term in low-risk pregnant female population. So, in one arm we will give Tab Mifepristone for induction and in the control arm expectant management will be done. 
Close